NYSE$SYK

Stryker Corp · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Reported solid first quarter results amidst a challenging macroeconomic environment and steady improvement of elective surgery volumes.

Stryker reported an 8.1% increase in net sales to $4.3 billion and a 9.2% increase in organic net sales. The company's reported EPS increased by 6.3% to $0.84, while adjusted EPS increased by 2.1% to $1.97.

  • Reported net sales increased 8.1% to $4.3 billion.
  • Organic net sales increased 9.2%.
  • Reported EPS increased 6.3% to $0.84.
  • Adjusted EPS increased 2.1% to $1.97.

Headline financials

Total Revenue

$4.28B

Previous: $3.95B+8.1%
EPS (adj)

$1.97

Previous: $1.93+2.1%
Organic Net Sales Growth

9.2%

Previous: 1.8%+411.1%
Capital Expenditures

-$119M

Previous: -$83M-43.4%
Free Cash Flow

$204M

Previous: $219M-6.8%
Net Income

$323M

Previous: $302M+7.0%
Operating Income

$447M

Previous: $459M-2.6%
Gross Profit

$2.73B

Previous: $2.51B+9.0%
Cash & Equivalents

$1.46B

Previous: $2.24B-34.9%
Total Assets

$36.1B

Previous: $33.5B+8.0%
Stock-Based Comp

$71M

Previous: $68M+4.4%

Revenue & EPS history

Stryker · Revenue · Quarterly

$4.28B

Q1 2022+8.1%vs Q1 2021
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Stryker · $1.53B total across 1 segment · Q3 2021

  • Orthopaedics
    $1.53B+16.1%

Forward guidance

The company now expects full year 2022 organic net sales growth towards the high end of their guidance range of 6% to 8%. Adjusted net earnings per diluted share is expected at the lower end of their guidance range of $9.60 to $10.00 per share.

Tailwinds

  • Strong orders for capital equipment.
  • Full year 2022 organic net sales growth towards the high end of guidance range of 6% to 8%.

Headwinds

  • Dynamic supply chain pressures.
  • COVID-19 pandemic uncertainty.
  • Expect net sales in the full year will be adversely impacted by approximately 1.2% due to foreign currency exchange rates.
  • Expect adjusted net earnings per diluted share will be adversely impacted by approximately $0.10 to $0.15 in the full year due to foreign currency exchange rates.
  • Considering the supply chain pressures and inflationary environment.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.7%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.7%

Avg return

30 days after

58%

42 / 73 earnings

Positive

+11.8%

Q4 2022

Best reaction

-6.3%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%-7.2%-3.0%
Q4 2025+2.6%+1.8%+9.4%
Q3 2025-3.0%-3.1%+0.6%
Q2 2025+0.0%-0.4%+3.6%
Q1 2025+1.0%+2.7%+2.3%
Q4 2024-2.2%-2.2%-2.8%
Q3 2024+2.1%+3.1%+9.0%
Q2 2024-1.7%-0.5%+7.4%
Q1 2024-3.2%-3.1%+0.5%
Q4 2023+6.7%+8.8%+11.0%
Q3 2023+1.5%+1.1%+9.5%
Q2 2023+3.3%+2.8%+3.6%
Q1 2023-1.9%-5.0%-8.0%
Q4 2022+11.8%+13.5%+5.0%
Q3 2022-4.0%-8.0%+2.0%
Q2 2022+5.1%+6.6%+7.5%
Q1 2022-3.2%-4.5%-5.1%
Q4 2021+0.1%+0.1%+7.1%
Q3 2021-0.9%+1.5%-9.3%
Q2 2021+2.0%+2.8%+2.9%
Q1 2021-2.1%-1.0%-4.1%
Q4 2020-3.4%-4.8%+2.0%
Q3 2020-1.4%+1.6%+13.6%
Q2 2020-4.0%-6.0%-1.6%
Q1 2020-6.3%-2.5%+1.6%
Q4 2019-1.8%-1.8%-9.2%
Q3 2019+1.6%-0.4%-4.1%
Q2 2019+0.4%+0.0%+0.2%
Q1 2019+1.6%+3.4%+1.3%
Q4 2018+10.7%+9.5%+16.4%
Q3 2018-1.7%-0.7%+1.0%
Q2 2018-2.7%-3.2%-3.0%
Q1 2018+3.2%+2.2%+5.1%
Q4 2017-2.6%-3.9%-5.6%
Q3 2017+6.4%+3.1%+3.0%
Q2 2017+1.4%+1.5%-4.0%
Q1 2017+1.3%+1.4%+4.8%
Q4 2016-0.2%+3.3%+3.6%
Q3 2016+4.0%+4.5%+2.7%
Q2 2016-4.4%-4.8%-7.0%
Q1 2016-0.4%
Q4 2015+4.4%
Q3 2015-5.4%
Q2 2015+2.5%
Q1 2015+3.3%
Q4 2014+0.2%
Q3 2014+1.0%
Q2 2014-0.2%
Q1 2014-1.1%
Q4 2013-1.0%
Q3 2013+2.7%
Q2 2013+2.2%
Q1 2013+1.1%
Q4 2012+2.8%
Q3 2012+0.3%
Q2 2012-2.9%
Q1 2012+2.2%
Q4 2011-0.0%
Q3 2011-2.9%
Q2 2011-0.3%
Q1 2011+0.2%
Q4 2010+1.9%
Q3 2010+2.3%
Q2 2010-0.7%
Q1 2009-1.1%
Q1 2010+0.2%
Q4 2009+1.9%
Q4 2007+1.9%
Q3 2008+2.9%
Q3 2009+2.9%
Q2 2009+5.1%
Q2 2008+5.1%
Q4 2008+5.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro